Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 912 across all filing types
Latest filing 2025-02-20 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Appointment of Non-Executive Independent Directors.
Regulatory Filings
2025-02-20 English
Appointment of Non-Executive Independent Directors in the Company.
Regulatory Filings
2025-02-20 English
Change in Director(s)
Regulatory Filings
2025-02-20 English
Intimation under Regulation 30 on appointment of Mr. Manojkumar Khubchand Gursahani and Mr. Pallavur Sankar Dass Vaidyanathan as the Non-Executive Independent Director of the Company.
Regulatory Filings
2025-02-20 English
Appointment
Regulatory Filings
2025-02-20 English
Appointment
Regulatory Filings
2025-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.